Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Endogenous Metabolite
    (49)
  • Apoptosis
    (35)
  • Autophagy
    (25)
  • Antibacterial
    (13)
  • NF-κB
    (11)
  • PDGFR
    (9)
  • c-Kit
    (9)
  • Raf
    (8)
  • VEGFR
    (8)
  • Others
    (489)
Filter
Search Result
Results for "

22-hdha

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    885
    TargetMol | Inhibitors_Agonists
  • Compound Libraries
    2
    TargetMol | Compound_Libraries
  • Peptide Products
    63
    TargetMol | Peptide_Products
  • Inhibitory Antibodies
    8
    TargetMol | Inhibitory_Antibodies
  • Dye Reagents
    7
    TargetMol | Dye_Reagents
  • PROTAC Products
    25
    TargetMol | PROTAC
  • Natural Products
    293
    TargetMol | Natural_Products
  • Recombinant Protein
    485
    TargetMol | Recombinant_Protein
  • Isotope Products
    20
    TargetMol | Isotope_Products
  • Antibody Products
    59
    TargetMol | Antibody_Products
  • Disease Modeling
    4
    TargetMol | Disease_Modeling_Products
  • Cell Research
    12
    TargetMol | Inhibitors_Agonists
22-HDHA
T3599790780-46-4
22-HDHA is an oxidation product of docosahexaenoic acid (DHA).
  • $1,050
35 days
Size
QTY
Sorafenib
Bay 43-9006
T0093L284461-73-0
Sorafenib (Bay 43-9006) is a multikinase inhibitor that targets Raf-1, B-Raf, VEGFR2, VEGFR3, VEGFR4, PDGFRβ, FLT3, c-Kit, and others (IC50=6/22/90/15/20/20/57/58 nM) with oral activity. It exhibits antitumor properties and can induce autophagy, apoptosis, and agonistic iron death.
  • $34
In Stock
Size
QTY
Liproxstatin-1
T2376950455-15-9
Liproxstatin-1 is a potent and selective inhibitor of ferroptosis (IC50=22 nM). Liproxstatin-1 protects cells from ferroptosis induced by ferroptosis inducers (e.g., Erastin, RSL3).
  • $33
In Stock
Size
QTY
TargetMol | Inhibitor Hot
Lenvatinib
E7080
T0520417716-92-8
Lenvatinib (E7080) is a multi-target receptor tyrosine kinase inhibitor that inhibits VEGFR1-3, FGFR1-4, KIT, PDGFR, and RET, and has oral activity. Lenvatinib has the strongest inhibitory activity on VEGFR2 and VEGFR3 (IC50=4/5.2 nM). Lenvatinib has strong anti-tumor activity.
  • $40
In Stock
Size
QTY
TargetMol | Inhibitor Hot
Rutin
Rutoside, Quercetin 3-O-rutinoside
T0795153-18-4
Rutin (Quercetin 3-O-rutinoside), a flavonoid, has a variety of biological activities including antiallergic, anti-inflammatory, antiproliferative, and anticarcinogenic properties.
  • $36
In Stock
Size
QTY
TargetMol | Inhibitor Hot
Paclitaxel
Taxol, NSC 125973
T096833069-62-4
Paclitaxel (Taxol) is a natural product and a microtubule polymer stabilizer. Paclitaxel has anti-tumor activity and causes cell death by inducing mitotic arrest, apoptosis, and cell autophagy.
  • $34
In Stock
Size
QTY
TargetMol | Inhibitor Hot
Temozolomide
TZM, TMZ, NSC 362856, CCRG 81045
T117885622-93-1
Temozolomide (TMZ) is a DNA alkylating agent with blood-brain barrier permeability and oral activity. Temozolomide has antitumor activity and antiangiogenic activity, and also induces apoptosis and autophagy. Temozolomide is stable under acidic conditions and hydrolyzes under neutral or slightly alkaline conditions.
  • $42
In Stock
Size
QTY
TargetMol | Inhibitor Hot
Lipopolysaccharides
LPS
T11855
Lipopolysaccharides (LPS), derived from Escherichia coli O55:B5, are essential components of the outer membrane of Gram-negative bacteria. Composed of lipid A, a core oligosaccharide, and an O-specific polysaccharide, LPS exhibits strong immunogenicity. It activates immune cells via the TLR4 receptor, induces chemotactic cell migration and cytokine secretion, and helps maintain the integrity of the bacterial outer membrane, protecting against bile salts and lipid-based antibiotics. LPS is commonly used to establish inflammatory models, including arthritis, chronic obstructive pulmonary disease (COPD), acute respiratory distress syndrome (ARDS), and gastrointestinal disease models.
  • $45
In Stock
Size
QTY
TargetMol | Inhibitor Hot
Suramin Sodium Salt
Suramin hexasodium salt, NF-060, BAY-205
T2160129-46-4
Suramin Sodium Salt (BAY-205) is a sodium salt form of suramin, a polysulphonated naphthylurea with potential antineoplastic activity. Suramin blocks the binding of various growth factors, including insulin-like growth factor I (IGF-I), epidermal growth factor (EGF), platelet-derived growth factor (PDGF), and tumor growth factor-beta (TGF-beta), to their receptors, thereby inhibiting endothelial cell proliferation and migration. This agent also inhibits vascular endothelial growth factor (VEGF)- and basic fibroblast growth factor (bFGF)-induced angiogenesis; retroviral reverse transcriptase; uncoupling of G-proteins from receptors; topoisomerases; cellular folate transport; and steroidogenesis.
  • $35
In Stock
Size
QTY
TargetMol | Inhibitor Hot
Resmetirom
VIA-3196, MGL3196
T3595920509-32-6
Resmetirom (MGL-3196) is a THR-β agonist (EC50=0.21 μM), with high selectivity and oral activity. Resmetirom can be used in the research of non-cirrhotic and non-alcoholic steatohepatitis.
  • $33
In Stock
Size
QTY
TargetMol | Inhibitor Hot
Fiduxosin
ABT 980, A 185980.1
T11286208993-54-8In house
Fiduxosin is a selective and potent α1-adrenoceptor antagonist with inhibitory effects on α1a-adrenoceptor, α1b-adrenoceptor and α1d-adrenoceptor, with Ki values of 0.160 nM, 24.9 nM and 0.920 nM, respectively. Fiduxosin can be used for the treatment of benign prostatic hyperplasia.
  • $700
In Stock
Size
QTY
Mutant IDH1-IN-2
T121281429176-69-1In house
Mutant IDH1-IN-2 is an inhibitor of mutant Isocitrate dehydrogenase (IDH) proteins, with an IC50 of 16.6 nM in fluorescence biochemical assay and an IC50 of <22 nM in LS-MS biochemical assay.
  • $58
In Stock
Size
QTY
Y1 receptor antagonist 1
H 409-22 isomer
T12155221697-09-2In house
Y1 receptor antagonist 1 (H 409-22 isomer) is the active isomer of H-409 22, a neuropeptide Y (NPY) Y1 receptor antagonist that dose-dependently antagonizes the vascular response to exogenous and endogenous NPY in pigs. lagodeoxycholic acid (H 409-22 isomer) is the active isomer of H-409 22, an antagonist of neuropeptide Y (NPY) Y1 receptor.
  • $2,120
10-14 weeks
Size
QTY
PD-1-IN-22
T123792349372-98-9In house
PD-1-IN-22 is a potent inhibitor of the programmed cell death-1 (PD-1)/programmed cell death-ligand 1 (PD-L1) interaction, with an IC50 of 92.3 nM.
  • $117
In Stock
Size
QTY
T-448
T448, T 448
T130571597426-53-3In house
T-448 is a specific, orally active, and irreversible inhibitor of lysine-specific demethylase 1 (LSD1, an H3K4 demethylase) with an IC50 of 22 nM.
  • $455
In Stock
Size
QTY
AZD-0284
T143692101291-07-8In house
AZD-0284 is an inverse agonist of the nuclear receptor RORγ. In development for the treatment of plaque psoriasis vulgaris and respiratory tract disorders[1].
  • $37
In Stock
Size
QTY
GS-6201
CVT-6883
T15418752222-83-6In house
GS-6201 (CVT-6883) is a selective antagonist of the adenosine A2B receptor, demonstrating high affinity and selectivity with a Ki of 22 nM for human adenosine A2B receptors.
  • $32
In Stock
Size
QTY
SSR180711 hydrochloride
SSR-180711C HCl, SSR-180711A HCl, SR-180711 HCl
T28856446031-79-4In house
SSR180711 hydrochloride (SSR-180711A HCl) is a selective Alpha7 nicotinic acetylcholine partial agonist for the study of neurodegenerative and cognitive disorders.
  • $30
In Stock
Size
QTY
Safotibant
LF22-0542, LF-22-0542, LF-220542, LF220542, LF 22-0542, LF 220542
T34485633698-99-4In house
Safotibant (LF-22-0542) is a bradykinin B1 receptor antagonist with anti-inflammatory and analgesic activity for the topical treatment of diabetic macular edema.
  • $88
In Stock
Size
QTY
(Iso)-MS4322
YS43-22 (isomer), MS4322 (isomer), (Iso)-YS43-22
T402332601727-80-2In house
(Iso)-MS4322 ((Iso)-YS43-22) is a selective and potent protein arginine methyltransferase 5 (PRMT5) degrader with potential anticancer activity that effectively reduces PRMT5 protein levels in MCF-7 cells and inhibits the growth of a wide range of cancer cells.
  • $489 TargetMol
In Stock
Size
QTY
PTP1B-IN-22
T6789386109-60-6In house
PTP1B-IN-22 is a protein tyrosine phosphatase 1B (PTP1B) inhibitor that inhibits glucose uptake in skeletal muscle L6 myotubes.
  • $36
In Stock
Size
QTY
Tebufelone
T68155112018-00-5In house
Tebufelone is a potent in vitro inhibitor of CO , a novel non-steroidal anti-inflammatory drug (NSAID) belonging to the di-tert-butylphenol (DTBP) class that has shown potent anti-inflammatory, analgesic and anti-reticulitis properties in various animal models. Tebufelone potently inhibits the formation of prostaglandins (PGE2) and blocks the formation of lipoxygenase pathway products [leukotriene (LTB4)] in rat macrophages (IC50 = 20 microM) and human whole blood (IC50 = 22 microM) in vitro. = 20 microM) and human whole blood (IC50 = 22 microM) from the formation of lipoxygenase pathway products [leukotriene (LTB4)] in vitro.
  • $52
In Stock
Size
QTY
Antimicrobial agent-22
THI 6c
T794682373339-51-4In house
Antimicrobial agent-22 (THI 6c) is a broad-spectrum, multi-target antibacterial with rapid bactericidal efficacy, effective anti-biofilm activity, and low cytotoxicity and hemolytic properties [1].
  • $293
In Stock
Size
QTY
6-Methoxynaringenin
TN317694942-49-1In house
6-Methoxynaringenin is an aerial part of Scutellaria barbata D. Don (Lamiaceae) and inhibits NO production efficiently with an IC50 value of 25.8 μM.
  • $461
Backorder
Size
QTY